Recognition of early mortality in multiple myeloma by a prediction matrix

Early mortality (EM; death ≤ 6 months from diagnosis) has been reported in several newly diagnosed multiple myeloma (NDMM) trials. Before the era of novel agents, the incidence was 10%‐14%. Causes of death included infections/pneumonia, renal failure, refractory disease, and cardiac events. Staging...

Descripción completa

Detalles Bibliográficos
Autores principales: Terebelo, Howard, Srinivasan, Shankar, Narang, Mohit, Abonour, Rafat, Gasparetto, Cristina, Toomey, Kathleen, Hardin, James W., Larkins, Gail, Kitali, Amani, Rifkin, Robert M., Shah, Jatin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601204/
https://www.ncbi.nlm.nih.gov/pubmed/28543165
http://dx.doi.org/10.1002/ajh.24796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601204/
https://www.ncbi.nlm.nih.gov/pubmed/28543165
http://dx.doi.org/10.1002/ajh.24796

Ejemplares similares